Aurelie Garant, M.D.

Director of Brachytherapy Program

Harold C. Simmons Comprehensive Cancer Center

Radiation Oncology
Genitourinary Cancer
Kidney Cancer

New Patient Appointment Accepting Virtual Visits or 214-645-8300

Biography

Aurelie Garant, M.D., is an Assistant Professor of Radiation Oncology and Director of Brachytherapy Program at UT Southwestern Medical Center. She is board certified in radiation oncology by the American Board of Radiology.

Dr. Garant earned her medical degree at Université Laval, Canada, followed by a residency at McGill University Health Centre and a fellowship at Mayo Clinic in advanced radiation oncology. In 2015, she received the McGill University Residency Program award, and in 2017, the John D. Earle Fellowship at the Mayo Clinic.

In 2020, Dr. Garant received a Diploma of the Royal College of Physicians and Surgeons of Canada for focused competency in brachytherapy.

Education & Training

Fellowship - Mayo Clinic (2017-2018), Advanced Radiation Oncology
Residency - McGill University Health Centre (2012-2017), Radiation Oncology
Medical School - Université Laval, Canada (2007-2012)

Honors & Awards

Texas Super Doctors, Rising Star 2022
Texas Super Doctors, Rising Star 2021
Texas Super Doctors, Rising Star 2020
NIH Kidney Cancer SPORE Career Enhancement Program Award 2019
UT Southwestern Leaders Emerging in Academic Departments (LEAD) Course: Class of 2019 2019
Reviewer (by invitation), International Journal of Radiation Oncology Biology Physics 2018
American Brachytherapy Society Prostate LDR/HDR Scholarship 2018
John D. Earle Radiation Oncology Fellowship Fund, Mayo Clinic, Rochester MN 2017-2018
McGill University Residency Program Award – Scholar 2015-2016
CIHR Travel Award Recipient for research presented abroad 2015
McGill University Residency Program Award – Collaborator/Manager 2014-2015
Chief Resident, Radiation Oncology Residency Program, McGill University, Canada 2014-2015

Books & Publications

Books
- Surgical Techniques in Rectal Cancer in Neoadjuvant Radiotherapy
  Vuong T, Garant A (2018), New York City, Springer
- Current Therapy in Colon and Rectal Surgery in Cancer of the Rectum: Neoadjuvant Therapy
  Vuong T, Garant A, Niazi T (2016), Amsterdam, Elsevier Sciences
Publications
- Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
  Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G Annals of surgical oncology 2012 Apr 19 4 1199-205
- EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
  Paliga A, Onerheim R, Gologan A, Chong G, Spatz A, Niazi T, Garant A, Macheto D, Alcindor T, Vuong T British journal of cancer 2012 Nov 107 11 1864-8
- Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
  Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N Clinical lung cancer 2017 09 18 5 565-571
- Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?
  Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T International journal of colorectal disease 2018 Jun 33 6 727-733
- Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
  Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, International journal of radiation oncology, biology, physics 2019 10 105 2 367-375
- Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer.
  Garant A, Magnan S, Devic S, Martin AG, Boutros M, Vasilevsky CA, Ferland S, Bujold A, DesGroseilliers S, Sebajang H, Richard C, Vuong T, International journal of radiation oncology, biology, physics 2019 12 105 5 1005-1011
- Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer.
  Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB, Practical radiation oncology 2019 Nov 9 6 e528-e533
- A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer.
  Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL, Practical radiation oncology 2019 Nov 9 6 410-417
- Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial.
  Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2021 02 155 237-245
- Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.
  Hannan R, Christensen M, Hammers H, Christie A, Paulman B, Lin D, Garant A, Arafat W, Courtney K, Bowman I, Cole S, Sher D, Ahn C, Choy H, Timmerman R, Brugarolas J, European urology oncology 2021 Dec
- A Multi-institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer.
  Garant A, Spears G, Routman D, Whitaker T, Liao Z, Harmsen W, Liu A, Haddock M, Hallemeier C, Lin S, Merrell K, Practical radiation oncology 2021 Jan
- Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy.
  McLaughlin MF, Folkert MR, Timmerman RD, Hannan R, Garant A, Hudak SJ, Costa DN, Desai NB, Advances in radiation oncology 2021 Jul-Aug 6 4 100713
- Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.
  Miranda AF, Howard JM, McLaughlin M, Meng X, Clinton T, Sanli Ö, Garant A, Bagrodia A, Margulis V, Lotan Y, Hannan R, Desai N, Woldu SL, Urologic oncology 2021 Jun
- Stereotactic Ablative Radiotherapy for High-Risk Prostate Cancer-a Prospective Multi-level MRI-based Dose Escalation Trial.
  Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine A, Kim DWN, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, TimmermanMD RD, International journal of radiation oncology, biology, physics 2021 Nov
- Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma.
  Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R, Advances in radiation oncology 2021 Sep-Oct 6 5 100692
- Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer.
  Chen L, Gannavarapu BS, Desai NB, Folkert MR, Dohopolski M, Gao A, Ahn C, Cadeddu J, Bagrodia A, Woldu S, Raj GV, Roehrborn C, Lotan Y, Timmerman RD, Garant A, Hannan R, Frontiers in oncology 2022 12 779182
- A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy.
  Balagopal A, Nguyen D, Morgan H, Weng Y, Dohopolski M, Lin MH, Barkousaraie AS, Gonzalez Y, Garant A, Desai N, Hannan R, Jiang S, Medical image analysis 2021 May 72 102101
- A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.
  Siddiqui MRS, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, Vuong T, Artho G, Rasheed S, Tekkis P, Abulafi AM, Brown G British journal of cancer 2017 Jun 116 12 1513-1519
- Image-guided adaptive endorectal brachytherapy in the nonoperative management of patients with rectal cancer
  Garant A, Magnan S, Devic S, Martin AG, et al International Journal of Radiation Oncology ? Biology ? Physics 2019 105 5 1005-1011
- PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumes.
  Balagopal A, Morgan H, Dohopolski M, Timmerman R, Shan J, Heitjan DF, Liu W, Nguyen D, Hannan R, Garant A, Desai N, Jiang S, Artificial intelligence in medicine 2021 11 121 102195
- A comparison of patient-reported health-related quality of life during proton versus photon chemoradiotherapy for esophageal cancer
  Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon SS, Merrell KW, Haddock MG, Hallemeier CL Practical Radiation Oncology 2019 9 6 410-417
- Intensity-modulated radiation therapy for patients with rectal cancer.
  Vuong T, Garant A Colorectal Cancer 2014 3 4 235-238
- Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer.
  Yau I, Vuong T, Garant A, Ducruet T, Doran P, Faria S, Liberman S, Richard C, Letellier F, Charlebois P, Loungnarath R, Stein B, Devic S International journal of radiation oncology, biology, physics 2009 Aug 74 5 1481-6
- Addition of iodinated contrast to rectal hydrogel spacer to facilitate MRI-independent target delineation and treatment planning for prostate cancer
  Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB Practical Radiation Oncology 2019 9 6 528-533
- Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
  Garant A, Des Groseilliers S, Martin L, Ferland É, Vuong T Clinical oncology (Royal College of Radiologists (Great Britain)) 2011 Sep 23 7 497-8
- Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer
  Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman IA, Singla N, Hammers H, Courtney KD, Bagrodia A, Margulis V, Desai NB, Garant A, Choy H, Timmerman RD, Brugarolas JB, Hannan R. International Journal of Radiation Oncology ? Biology ? Physics 2019 105 2 367-375
- Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity.
  Liang Y, Hannan R, Fu YX, Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Mar
- What Is the Optimal Radiation Technique for Esophageal Cancer? A Dosimetric Comparison of Four Techniques.
  Fawaz ZS, Kazandjian S, Tsui JM, Devic DS, Lecavalier-Barsoum M, Vuong T, Elakshar S, Garant A, Lavoie I, Niazi TM Cureus 2018 Jul 10 7 e2985
- Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review.
  Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T Critical reviews in oncology/hematology 2017 Dec 120 86-92
- A comparison of grade 4 lymphopenia with proton versus photon radiotherapy for esophageal cancer. Advances in radiation oncology
  Routman DM, Garant A, Lester SC, Cristobal CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW 2019 4 1 63-69
- The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer.
  Dohopolski M, Hannan R, Wardak Z, Hammers H, Garant A, Cancer journal (Sudbury, Mass.) 2020 Sep/Oct 26 5 448-459
- Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC.
  All S, Garant A, Hannan R, Seminars in radiation oncology 2021 Jul 31 3 227-234
- Stereotactic Ablative Radiotherapy for Oligoprogressive Renal Cell Carcinoma, Advances in Radiation Oncology
  Schoenhals J, Mohamad O, Christie A, Zhang Y, Singla N, Bowman IA, Hammers HJ, Courtney KD, Cole S, Bagrodia A, Margulis V, Desai NB, Garant A, Choy H, Timmerman RD, Brugarolas J, Hannan R Advances in Radiation Oncology 2001 6 5 100692
- Whole Abdominal-Pelvic Radiotherapy in the Management of Primary Ewing Sarcoma of the Peritoneal Cavity.
  Barbosa Neto O, Garant A, Shakir S, Brossard J, Garde-Granger P, Freeman C Cureus 2016 Jan 8 1 e455
- Optimization of HDRBT boost dose delivery for patients with rectal cancer
  Devic S, Bekerat H, Garant A, Vuong T Brachytherapy 2019 18 4 559-563
- Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation.
  Desai NB, Garant A, Hannan R, Folkert MR, International journal of radiation oncology, biology, physics 2020 11 108 4 914-916
- Dosimetric impact of physician style variations in contouring CTV for post-operative prostate cancer: A deep learning-based simulation study
  Balagopal A, Nguyen D, Mashayekhi M, Morgan H, Garant A, Desai N, Hannan R, Lin M.H., Jiang S arXiv 2021

Research

RCC spine metastases
Bladder cancer in women
Prostate cancer protocols
Rectal cancer in elderly patients

Clinical Focus

Genitourinary Cancer
Kidney Cancer
Prostate Cancer

New Patient Appointment Accepting Virtual Visits or 214-645-8300 or 817-882-2400